Table 2 Socio-demographic characteristics and primary outcomes for the first N = 125 ENHANCE project clients at enrollment
Characteristic | N (%) |
|---|---|
Total | 125 |
Age, Median (Range) | 40.5 (23.0, 65.0) |
Race | |
American Indian or Alaska Native | 9 (7.2) |
Black | 30 (24.0) |
White | 82 (65.6) |
Prefer not to answer | 4 (3.2) |
Hispanic Ethnicity | 13 (10.4) |
Gender | |
Male | 79 (63.2) |
Female | 43 (34.4) |
Transgender, gender-queer, nonbinary, questioning gender identity, or something else | 3 (2.4) |
High school/GED or higher education | 106 (84.8) |
Used heroin or fentanyl in the past 30 days | 88 (70.4) |
Used methamphetamine, crystal meth, crack, or cocaine in the past 30 days | 116 (92.8) |
Used prescription opiate pain relievers not as prescribed by smoking/vaping, snorting, or injecting in the past 30 days | 36 (28.8) |
Experienced an opioid overdose in the past 6Â months | 28 (22.4) |
Overamped (adverse effect from taking stimulants) in the past 6Â months | 48 (38.4) |
Overdose risk behaviors in the past 30 days | Mean (SD) days |
Injected fentanyl | 7.8 (12.0) |
Injected heroin | 9.3 (12.8) |
Injected methamphetamine | 5.4 (8.9) |
Injected cocaine | 3.6 (8.2) |
Used methamphetamine and fentanyl concurrently | 3.5 (8.3) |
Used methamphetamine and heroin concurrently | 2.0 (6.3) |
Used cocaine and fentanyl concurrently | 3.4 (9.0) |
Used cocaine and heroin concurrently | 4.1 (9.3) |
Used fentanyl and xylazine concurrently | 1.7 (6.0) |
Used opioids and alcohol within a 6 h time period | 4.7 (8.9) |
Used opioids and benzodiazepines within a 6 h time period | 4.8 (9.4) |
Used opioids and any stimulant within a 6 h time period | 11.2 (11.5) |
Solitary opioid use | 9.9 (10.7) |
Solitary stimulant use | 11.0 (11.7) |